synthesi
serin
deriv
essenti
function
group
inhibitor
sar
proteas
evalu
inhibitori
activ
use
sar
mutant
proteas
describ
lead
compound
function
serin
deriv
design
base
tetrapeptid
aldehyd
bai
cinnamoli
inhibitor
addit
perform
simul
gold
softwear
structur
activ
relationship
studi
candid
compound
given
reason
inhibitor
sar
mutant
proteas
inhibitor
show
proteas
select
cytotox
sever
acut
respiratori
syndrom
sar
contagi
respiratori
diseas
human
caus
sar
coronaviru
sarscov
atyp
pneumonia
due
sarscov
lead
progress
respiratori
failur
individu
death
within
month
thereaft
sar
epidem
success
control
potenti
reemerg
pandem
sarscov
continu
risk
new
strain
sar
sarslik
viru
could
potenti
infecti
strain
led
outbreak
two
human
coronavirus
identifi
patient
around
world
sinc
recent
identifi
human
coronaviru
middl
east
respiratori
syndrom
coronaviru
merscov
infect
peopl
sinc
april
nearli
mortal
rate
number
keep
rise
daili
two
asian
bat
coronavirus
shown
closest
relat
merscov
possibl
futur
sarslik
pandem
remain
vaccin
antivir
agent
yet
develop
prevent
treat
sarslik
infect
sarscov
novel
human
coronaviru
featur
largest
positivestrand
rna
genom
known
date
kb
kb
key
enzym
process
polyprotein
translat
viral
rna
genom
sarscov
kda
proteas
call
proteas
proteas
sar
proteas
cystein
proteas
contain
cyshi
catalyt
dyad
cleav
precursor
polyprotein
mani
conserv
site
involv
conserv
gln
posit
small
amino
acid
ser
ala
gli
p
posit
due
function
import
viral
life
cycl
sar
proteas
consid
attract
target
drug
design
treat
sar
varieti
inhibitor
sar
proteas
report
literatur
past
decad
includ
substratebas
peptidemimet
fravonoid
deriv
tannin
deriv
isatin
deriv
decaisoquinolin
etc
howev
effect
therapeut
drug
vaccin
develop
date
although
mani
candid
antisar
cov
agent
identifi
previou
studi
report
design
synthesi
peptid
aldehyd
inhibitor
acthrvalchahish
show
high
inhibitori
activ
ic
valu
nm
toward
mutant
proteas
substrat
mimet
concept
inhibitor
optim
screen
site
residu
previou
report
peptid
aldehyd
inhibitor
acseralavalleugln
h
except
site
sidechain
direct
outsid
made
interact
proteas
guid
xray
crystal
structur
lead
compound
bound
mutant
sar
proteas
interact
inhibitor
site
proteas
seem
effect
addit
new
synthet
method
use
acet
http
aldehyd
convers
via
thioacet
format
describ
afford
ctermin
peptid
aldehyd
side
chain
structur
site
cterminu
aldehyd
thiol
captur
tetrapeptid
inhibitor
thought
critic
role
potent
inhibitori
activ
contrast
gener
enzymat
digest
peptid
chain
aproton
racem
andor
low
specif
aldehyd
function
develop
nonpeptidyl
small
molecular
inhibitor
sar
proteas
focus
site
interact
aim
design
synthes
serin
deriv
essenti
function
group
evalu
inhibitori
activ
present
studi
serin
commerci
avail
proteinogen
amino
acid
three
variant
reaction
site
alcohol
amin
carboxyl
acid
orthogon
connect
variou
function
group
fig
determin
whether
seri
serin
deriv
could
adopt
energet
favor
conform
mimick
tetrapeptid
inhibitor
perform
varieti
molecular
mechan
calcul
spartan
wavefunct
dock
simul
protein
interact
gold
ccdc
firstli
imidazol
cyclohexyl
hydroxi
group
optim
function
potent
biolog
activ
previou
literatur
connect
lserin
design
serin
deriv
b
shown
scheme
howev
give
good
coverag
substraterecognit
pocket
proteas
pdb
code
interact
optim
motif
correspond
pocket
differ
bind
mode
contrari
expect
cyclohexyl
group
serin
deriv
occupi
pocket
proteas
imper
thu
imidazol
hydroxi
group
serin
deriv
expect
interact
pocket
effect
consequ
number
interact
atom
pair
inhibitor
sarscov
proteas
diminish
contrast
bai
report
cinnamoyl
deriv
inhibit
sarscov
proteas
case
bai
inhibitor
locat
deep
insid
pocket
appropri
cinnamoyl
function
result
approxim
identifi
bai
simul
employ
autodock
estim
free
energi
bind
dock
bai
inhibitor
sar
proteas
pdb
code
therefor
examin
molecular
dock
serin
deriv
contain
togeth
benzoyl
anilin
moieti
give
attract
ligand
proteas
furthermor
investig
reason
structur
inhibitor
mode
hybrid
compound
bai
function
serin
deriv
result
conclud
reason
structur
ncinnamoyl
deriv
benzoat
side
chain
virtual
screen
gold
compound
follow
characterist
sinc
substrat
natur
involv
small
amino
acid
ser
ala
gli
p
posit
may
prefer
adopt
aromat
ring
b
proper
placement
cyclohexyl
ring
may
result
develop
serin
type
inhibitor
function
posit
well
stabil
interact
posit
c
pocket
rather
hydrophob
natur
therefor
correspond
side
chain
name
aromat
hydrocarbon
neutral
function
make
good
contact
target
region
addit
region
adjac
ester
bond
catalyt
thiol
function
enzym
scheme
view
promis
comput
evalu
serin
deriv
term
tetrapeptid
mimet
plan
synthes
target
molecul
evalu
inhibitori
activ
serin
deriv
sarscov
proteas
structur
activ
relationship
studi
use
serin
deriv
attempt
depict
scheme
serin
deriv
attach
three
function
prepar
coupl
partner
introduc
function
shown
tabl
coupl
fmoclser
tbu
oh
amin
moieti
wschobt
follow
deprotect
fmoc
group
piperidinedmf
gave
serin
amid
deriv
accept
chemic
yield
moieti
introduc
coupl
carboxyl
acid
presenc
coupl
reagent
acyl
use
carboxyl
anhydrid
acyl
chlorid
afford
diamid
deriv
subsequ
treatment
tfa
deprotect
tbutyl
group
gave
alcohol
moder
yield
final
esterif
hydroxi
group
varieti
acyl
reagent
perform
give
novel
serin
deriv
evalu
small
molecular
inhibitor
sar
proteas
purif
crude
compound
perform
silica
gel
column
chromatographi
chemic
structur
synthet
compound
mainli
determin
h
c
nmr
ir
mass
spectra
scheme
depict
tabl
five
cyclic
function
attach
carboxyl
acid
serin
templat
mention
investig
import
cyclohexan
ring
defin
posit
treatment
fmoclser
tbu
oh
cyclohexylamin
wschobt
continu
fmocdeprotect
afford
yield
entri
abovement
condit
fmoclser
tbu
oh
subject
coupl
reaction
piperidin
morpholin
benzylamin
cyclohexylmethylamin
give
despit
poor
yield
entri
avail
evalu
inhibitori
activ
tabl
optim
function
varieti
carboxyl
acid
especi
bunsatur
carboxyl
acid
introduc
coupl
cinnam
acid
hatu
hoat
dipea
ch
cl
condit
follow
treatment
tfa
deprotect
tbutyl
group
afford
yield
entri
treatment
phydroxyphenyl
propano
acid
presenc
hatuhoatdipea
ch
cl
also
gave
yield
remov
tbutyl
group
entri
sinc
isol
condit
hatuhoat
found
dmtmm
condit
b
coupl
reagent
moder
give
yield
step
entri
attempt
improv
chemic
yield
coupl
reaction
cinnam
acid
deriv
amin
knew
hatu
dmtmm
coupl
reagent
use
preliminari
studi
reason
seri
cinnamoyl
deriv
also
prepar
ident
condit
moder
yield
entri
addit
acyl
benzoyl
chlorid
condit
c
success
perform
yield
without
problem
entri
tabl
structureact
relationship
studi
p
function
serin
deriv
prepar
serin
deriv
depict
tabl
acyl
substrat
employ
shiina
yamaguchi
condit
coupl
carboxyl
acid
acyl
chlorid
acet
anhydrid
reagent
use
commerci
avail
acyl
chlorid
ac
acyl
reagent
gave
correspond
ester
moder
yield
entri
esterif
nacetyllhistidin
shiina
reagent
nmbadmap
afford
hiscompound
extrem
low
yield
entri
case
byproduct
given
moder
yield
difficult
improv
chemic
yield
even
attempt
sever
condit
prepar
pglucompound
isonicotin
nicotin
also
result
similar
situat
entri
yamaguchi
protocol
perform
give
entri
also
acyl
chlorid
prepar
acid
acid
cinnam
acid
oxalyl
chlorid
presenc
dmf
situ
react
afford
low
yield
entri
hand
treatment
varieti
alcohol
bzclet
ndmap
ch
cl
convert
benzoyl
ester
chemic
yield
benzoyl
ester
variabl
use
substrat
entri
tabl
inhibit
sar
mutant
proteas
determin
previou
procedur
use
synthet
decapeptid
cleavag
sequenc
substrat
synthet
lserin
deriv
sever
structur
subclass
investig
cinnamoyllserin
deriv
modif
p
posit
tabl
benzoyllserin
deriv
modif
posit
tabl
depict
tabl
inhibitori
potenc
synthes
cinnamoyllserin
deriv
modif
p
posit
evalu
ic
valu
simul
compound
control
exhibit
ic
valu
lm
entri
sinc
ic
valu
previou
report
peptid
aldehyd
report
nm
imidazol
histidin
clactam
pyroglutam
acid
import
function
howev
coupl
pglu
show
low
inhibitori
activ
expect
dock
simul
entri
optim
p
function
group
differ
acyl
unit
alkyl
phenyl
pyridyl
group
examin
aliphat
groupscontain
compound
show
lower
inhibitori
activ
entri
pyridyl
deriv
also
similar
entri
aromat
ring
nitro
chlorid
methoxi
group
gave
moder
result
entri
phenylacet
also
show
lower
inhibitori
activ
entri
contrast
convers
phenylpropion
cinnnamoyl
group
p
site
would
expect
dramat
effect
inhibitori
activ
especi
cinnamoyl
compound
show
potent
inhibitori
activ
ic
valu
lm
entri
addit
deriv
show
good
potenti
proteas
inhibitor
entri
ic
valu
scheme
virtual
screen
serin
deriv
sarscov
proteas
pdb
code
gold
softwear
satur
compound
decreas
comparison
fix
unsatur
deriv
entri
result
suggest
serin
type
deriv
contain
optim
function
would
use
proteas
inhibitor
correl
ic
c
log
p
could
assum
potent
inhibitori
activ
tend
rel
high
lipophil
c
log
p
valu
tabl
achiev
optim
use
serin
templat
structur
activ
relationship
studi
function
r
lead
compound
conduct
aliphat
pivaloylcontain
compound
substitut
cinnamoyl
group
show
inhibitori
activ
introduct
benzoyl
group
make
signific
contribut
entri
next
modifi
cinnamoyl
group
design
moieti
site
replac
methoxi
connect
cinnamoyl
group
permit
moieti
fit
pocket
tightli
although
function
effect
compound
entri
inhibitor
contain
group
phenyl
ring
site
exhibit
markedli
increas
inhibitori
activ
entri
ic
valu
lm
result
suggest
planar
aromat
ring
hydrophob
function
essenti
factor
produc
reason
proteas
inhibitor
entri
correl
ic
c
log
p
difficult
explain
compound
close
molecular
formula
tabl
investig
import
cyclohexyl
group
site
evalu
four
deriv
combin
differ
amin
piperidin
morpholin
benzylamin
cyclohexylmethylamin
result
show
inhibitori
activ
compound
shorter
term
one
carbon
length
site
therefor
posit
inhibitor
show
decreas
flexibl
expect
hardli
fit
pocket
hand
aromat
benzyl
amin
compound
planer
structur
led
moder
inhibitori
activ
attempt
use
cyclohexylmethylamin
accept
show
ic
lm
suggest
cyclohexyl
structur
site
strictli
interact
hydrophob
pocket
mention
optim
function
p
site
lserin
templat
base
refer
compound
guid
virtual
screen
gold
p
site
prefer
similar
characterist
aromat
ring
sp
planer
structur
hydrophob
next
inhibitori
activ
select
serin
deriv
dform
evalu
base
ic
valu
ic
valu
tpsa
select
inhibitor
summar
tabl
prepar
dserin
deriv
perform
synthet
protocol
correspond
lserin
compound
without
problem
fmocdser
tbu
oh
start
materi
select
step
sequenc
perform
shown
scheme
interestingli
extrem
variant
ic
valu
land
dform
except
entri
enantiom
show
inhibitori
activ
entri
inhibitori
activ
lform
show
tendenc
potent
dform
entri
contrast
exhibit
potent
inhibitori
activ
proteas
tend
dform
potent
activ
lform
entri
guess
enantiom
fit
activ
site
proteas
via
differ
bind
mode
p
site
function
interact
pocket
consequ
site
group
locat
pocket
serin
deriv
high
flexibl
therefor
two
hydrophob
space
proteas
recogn
rigor
manner
enantiom
exhibit
potent
inhibitori
activ
ic
lm
evalu
compound
though
correl
ic
valu
tpsa
tabl
tpsa
valu
accept
toward
proteas
inhibitor
target
catalyt
domain
tabl
bind
mode
sar
proteas
predict
dock
simul
use
gold
ccdc
result
suggest
reason
inhibitor
assess
dock
simul
design
lead
effect
accept
structur
interestingli
interact
enzym
enantiom
serin
deriv
similar
word
function
p
site
dserin
templat
locat
pocket
respect
suggest
flexibl
backbon
recognit
function
serin
type
inhibitor
therefor
enantiom
design
compound
also
signific
candid
sar
proteas
inhibitor
moreov
may
consid
dserin
play
critic
role
digest
proteas
fig
import
enzym
select
develop
proteas
inhibitor
investig
inhibit
cathepsin
b
mammalian
cystein
proteas
involv
numer
patholog
process
cystein
proteas
inhibitor
hardli
inhibit
sar
proteas
previou
report
miraziridin
tokaramid
reason
inhibitor
bind
activ
site
cathepsin
b
reason
inhibitor
sar
proteas
thought
show
specif
endogen
proteas
therefor
attempt
evalu
inhibitori
activ
serin
deriv
cathepsin
b
inhibitori
activ
toward
cathepsin
b
determin
assay
use
zargargmca
substrat
develop
hiwasa
et
al
inhibit
potenc
serin
deriv
screen
cathepsin
b
inhibit
mm
concentr
subsequ
ic
valu
determin
select
compound
reason
inhibitor
enantiom
sar
mutant
proteas
good
potenti
cathepsin
b
inhibitor
shown
tabl
result
serin
deriv
exhibit
potent
inhibitori
activ
sar
proteas
show
rel
less
potent
inhibitori
effect
cathepsin
b
activ
high
proteas
select
entri
hand
three
compound
extract
screen
cathepsin
b
inhibitor
entri
compound
useless
sar
proteas
inhibit
tabl
inhibitori
activ
select
serin
deriv
evalu
use
correspond
ic
valu
ic
valu
synthet
lm
compar
ic
valu
sar
proteas
cathepsin
b
strongli
suggest
inhibitori
activ
attribut
mainli
ester
site
result
consist
structur
data
complex
cathepsin
b
suggest
site
easili
adopt
conform
similar
bind
mode
although
site
rather
weak
effect
compar
site
inhibitori
activ
time
estim
inhibitori
mechan
inhibitori
kinet
experi
perform
make
lineweaverburk
plot
rate
cleavag
differ
amount
substrat
cathepsin
b
absenc
presenc
lm
monitor
use
fluoresc
spectromet
consequ
competit
inhibit
toward
cathepsin
b
assess
cytotox
abil
serin
deriv
also
import
proteas
inhibitor
need
orthogon
relationship
antiviru
activ
cytotox
cytotox
assay
perform
hela
cell
use
synthes
serin
deriv
cytotox
alongsid
rotenon
serv
control
cytotox
compound
determin
measur
livecel
succinatetetrazolium
reductas
activ
mtt
assay
although
serin
deriv
enantiom
lm
concentr
evalu
hela
cell
cell
cell
death
ratio
caus
compound
less
therefor
show
practic
cytotox
inhibitori
activ
sar
proteas
cathepsin
b
show
ic
valu
lm
inhibit
mm
concentr
respect
moreov
inhibitori
effect
ic
lm
sar
proteas
ic
lm
cathepsin
b
result
indic
high
specif
two
proteas
addit
inhibitor
show
cytotox
therefor
good
potenti
drug
chosen
next
stage
design
respect
fig
conclus
found
effect
serin
deriv
toward
sar
proteas
inhibitor
combin
dock
simul
structur
activ
relationship
studi
consequ
two
attract
inhibitor
deriv
tetrapeptid
aldehyd
bai
inhibitor
produc
inhibitor
show
proteas
select
cytotox
therefor
use
methodolog
use
serin
templat
facilit
drug
design
especi
testifi
deriv
virtual
screen
reason
inhibitor
improv
inhibitori
activ
sar
proteas
molecular
design
evalu
underway
solvent
reagent
grade
ch
cl
distil
cah
commerci
reagent
highest
puriti
avail
amino
acid
deriv
purchas
watanab
chemic
industri
chemic
purchas
aldrich
wako
chemic
nacalai
tesqu
optic
rotat
determin
jasco
polarimet
sodium
line
ir
spectra
sampl
obtain
film
horiba
spectromet
h
mhz
ad
e
acid
mg
mmol
room
temperatur
ch
cl
nitrogen
atmospher
mixtur
stir
room
temperatur
min
solvent
evapor
vacuo
residu
ad
mixtur
mg
mmol
tea
ml
mmol
ch
cl
stir
room
temperatur
h
ch
cl
h
ad
solut
organ
layer
dri
mgso
solvent
evapor
vacuo
residu
purifi
silicagel
column
chromatographi
chcl
give
mg
lmol
enzym
assay
carri
use
recombin
sar
mutant
proteas
enzym
concentr
nm
reaction
mixtur
mm
acona
buffer
ph
contain
grecerol
mm
dtt
nacl
analyz
cosmosil
column
mm
employ
linear
gradient
mecn
min
aq
tfa
ic
valu
obtain
sigmoid
doserespons
curv
obtain
decreas
substrat
reaction
mixtur
experi
repeat
three
time
bovin
spleen
cathepsin
b
purchas
sigma
chemic
compani
st
loui
mo
mu
cathepsin
b
preincub
min
mm
me
ph
mm
dtt
solut
mix
mm
zargargmca
inhibitor
nm
mm
dmso
mixtur
incub
min
reaction
stop
ad
mm
sodium
monochloroacet
mm
sodium
acet
mm
acet
acid
ph
ic
valu
obtain
sigmoid
doserespons
curv
obtain
decreas
substrat
reaction
mixtur
experi
repeat
three
time
hela
cell
maintain
suspens
cultur
dmem
supplement
fb
fetal
bovin
serum
contain
penicillinstreptomycin
mixtur
aliquot
hela
cell
cellsml
ad
well
plate
incub
h
humidifi
incub
contain
co
air
h
aliquot
compound
serin
deriv
concentr
vari
rang
lm
rotenon
control
ad
well
incub
h
solut
mixtur
pm
ad
well
incub
continu
h
visibl
absorb
nm
nm
refer
wavelength
well
quantifi
use
micropl
reader
